Filter Search


Healthcare and Medical


Location Summary Deadline
France Innovative Telemedicine Devices And Services Facing The Challenges Of Medical Deserts 2026-04-25
Germany Openhouse Biological Discount Contracts 202525 Aflibercept (atc 2026-04-25
Germany Conclusion Not Excluding The Discount Agreement For Medicinal Products According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Teriparatide (atc Code According To Who 2026-04-25
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V With The Active Ingredient Aflibercept In A Strength Of 40mg/ml 2026-04-25
Germany Conclusion Not Excluding The Pharmaceutical Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Pamidronic Acid (atc Code According To Who 2026-04-25
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Sarilumab, Atc L04ac14 2026-04-25
Germany Conclusion Not Excluding The Drug Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tocilizumab (atc Code According To Who 2026-04-25
Germany Open House Original Discount Agreements 2025-34 - Formoterol/glycopyrronium/budesonide (combination Of Active Ingredients) 2026-04-26
Paraguay Lpn N° 04/2026 - Acquisition Of Reagents And Supplies For The Department Of Pathological Anatomy Mspbs 2026-04-26
France Innovative Telemedicine Devices And Services Facing The Challenges Of Medical Deserts 2026-04-26
Whats app